Structure via PubChem · Public domain (PubChem)
bromocriptina
Sign in to saveAlso known as PLO154, 2-bromoergocryptine, bromocryptine, CB-154, Parlodel®, (5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman, 2-bromo-alpha-ergokryptine, 2-bromo-alpha-ergokryptin
farmaco
Key facts
- Drug.StdInChI
- 1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1
- Drug.StdInChIKey
- OZVBMTJYIDMWIL-AYFBDAFISA-N
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 459983915
- Drug.image
- Bromocriptine.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 200px
- Drug.image2
- Bromocriptine molecule ball.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 250px
- Drug.tradename
- Parlodel, others
- Drug.MedlinePlus
- a682079
- Drug.pregnancy_AU
- A
- Drug.routes_of_administration
- Oral, vaginal, intravenous
- Drug.class
- Dopamine receptor agonist; Serotonin receptor agonist; Adrenergic receptor modulator; Antiparkinsonian agent; Prolactin inhibitor; Anti-diabetic drug
- Drug.ATC_prefix
- G02
- Drug.ATC_suffix
- CB01
- Drug.legal_AU
- S4
via Wikipedia infobox
Chemical data
- Formula
- C32H40BrN5O5
- Molecular weight
- 654.6 g/mol
- IUPAC name
- (6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
- SMILES
- CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O
- InChIKey
- OZVBMTJYIDMWIL-AYFBDAFISA-N
- XLogP
- 3.8
- Polar surface area
- 118 Ų
- H-bond donors
- 3
- H-bond acceptors
- 6
- Formal charge
- 0
via PubChem
Article · Italiano
La bromocriptina è un derivato semisintetico dell'ergotamina - un alcaloide naturale prodotto da Claviceps purpurea - che si comporta come un potente agonista dei recettori dopaminergici. Chimicamente è un derivato dell'. Funzionalmente è un agonista dopaminergico che può essere utilizzato nel trattamento di tumori ipofisari, Malattia di Parkinson, Iperprolattinemia, Sindrome Neurolettica Maligna e il Diabete Mellito tipo 2.
Abstract from DBpedia / Wikipedia · CC BY-SA